Envarsus XR 4 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FQS7D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,287
Award facts
- Contract value 100% obligated
- $23,286.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets (100-count) with a firm fixed price ceiling value of $23,286.60. The contract, issued as a competitive non-set-aside award on December 22, 2025, carries an ultimate completion date of January 14, 2026, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Envarsus XR is a tacrolimus immunosuppressant medication commonly used in transplant and autoimmune disease management.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills competitive delivery orders across diverse therapeutic domains under this prime contract framework.
Quick answers
Who was awarded contract SPE2DR26FQS7D?
SPE2DR26FQS7D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FQS7D worth?
The government has obligated $23,287 on SPE2DR26FQS7D.
Is contract SPE2DR26FQS7D an order under another contract?
Yes. SPE2DR26FQS7D is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS7D competed?
The extent of competition for SPE2DR26FQS7D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award